These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 8610052)

  • 1. Genetic mapping of allelic loss on chromosome 6q within heterogeneous prostate carcinoma.
    Konishi N; Nakamura M; Kishi M; Ishida E; Shimada K; Matsuyoshi S; Nagai H; Emi M
    Cancer Sci; 2003 Sep; 94(9):764-8. PubMed ID: 12967473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsatellite instability and other molecular abnormalities in human prostate cancer.
    Suzuki H; Komiya A; Aida S; Akimoto S; Shiraishi T; Yatani R; Igarashi T; Shimazaki J
    Jpn J Cancer Res; 1995 Oct; 86(10):956-61. PubMed ID: 7493915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome 10, frequently lost in human melanoma, encodes multiple tumor-suppressive functions.
    Kwong LN; Chin L
    Cancer Res; 2014 Mar; 74(6):1814-21. PubMed ID: 24453001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward Systems Pathology for PTEN Diagnostics.
    Haddadi N; Travis G; Nassif NT; Simpson AM; Marsh DJ
    Cold Spring Harb Perspect Med; 2020 May; 10(5):. PubMed ID: 31615872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leucine zipper tumor suppressor 2 inhibits cell proliferation and regulates Lef/Tcf-dependent transcription through Akt/GSK3β signaling pathway in lung cancer.
    Cui QZ; Tang ZP; Zhang XP; Zhao HY; Dong QZ; Xu K; Wang EH
    J Histochem Cytochem; 2013 Sep; 61(9):659-70. PubMed ID: 23761130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics of prostate cancer.
    Zhang KQ; Salzman SA; Reding DJ; Suarez BK; Catalona WJ; Burmester JK
    Clin Med Res; 2003 Jan; 1(1):21-8. PubMed ID: 15931281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of expression of human spectrin src homology domain binding protein 1 is associated with 10p loss in human prostatic adenocarcinoma.
    Macoska JA; Xu J; Ziemnicka D; Schwab TS; Rubin MA; Kotula L
    Neoplasia; 2001; 3(2):99-104. PubMed ID: 11420744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic analysis of prostatic atypical adenomatous hyperplasia (adenosis).
    Doll JA; Zhu X; Furman J; Kaleem Z; Torres C; Humphrey PA; Donis-Keller H
    Am J Pathol; 1999 Sep; 155(3):967-71. PubMed ID: 10487854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men.
    Nastiuk KL; Mansukhani M; Terry MB; Kularatne P; Rubin MA; Melamed J; Gammon MD; Ittmann M; Krolewski JJ
    Prostate; 1999 Aug; 40(3):172-7. PubMed ID: 10398279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infrequent mutations in the PTEN/MMAC1 gene among primary breast cancers.
    Ueda K; Nishijima M; Inui H; Watatani M; Yayoi E; Okamura J; Yasutomi M; Nakamura Y; Miyoshi Y
    Jpn J Cancer Res; 1998 Jan; 89(1):17-21. PubMed ID: 9510470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer.
    Gao X; Zacharek A; Salkowski A; Grignon DJ; Sakr W; Porter AT; Honn KV
    Cancer Res; 1995 Mar; 55(5):1002-5. PubMed ID: 7866981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.
    Gao X; Porter AT; Honn KV
    Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic changes associated with prostate cancer in humans.
    Isaacs WB; Carter BS
    Cancer Surv; 1991; 11():15-24. PubMed ID: 1841750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma.
    Ittmann MM
    Prostate; 1996 May; 28(5):275-81. PubMed ID: 8610052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions.
    Latil A; Cussenot O; Fournier G; Driouch K; Lidereau R
    Cancer Res; 1997 Mar; 57(6):1058-62. PubMed ID: 9067271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity at 7q31.1 and 12p13-12 in advanced prostate cancer.
    Kawana Y; Ichikawa T; Suzuki H; Ueda T; Komiya A; Ichikawa Y; Furuya Y; Akakura K; Igarashi T; Ito H
    Prostate; 2002 Sep; 53(1):60-4. PubMed ID: 12210480
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.